Evidence map›Paper›PMID 28025363›Full record

ArticlePain medicine (Malden, Mass.)2016

National Action Plan for Adverse Drug Event Prevention: Recommendations for Safer Outpatient Opioid Use.

Aaron R Ducoffe, Andrew York, Dale J Hu, Deborah Perfetto, Robert D Kerns

Open access · hybridAbstract read
In one paragraph

Article in Pain medicine (Malden, Mass.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pharmacogenetics and Molecular Ancestry ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Aaron R Ducoffe*Previously with Office of Disease Prevention and Health Promotion (ODPHP), US Department of Health and Human Services, Washington, DC; Currently with MedStar Georgetown University Hospital, Department of Radiology, Washington, DC.
Andrew YorkPreviously with ODPHP, Washington, DC; Currently with Centers for Medicare & Medicaid Services, Baltimore, Maryland.
Dale J HuPreviously with ODPHP, Washington, DC; Currently with National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland.
Deborah PerfettoAgency for Healthcare Research and Quality, Rockville, Maryland.
Robert D KernsPreviously with the Pain Research, Informatics, Multi-Morbidities and Education (PRIME) Center, Virginia Connecticut Healthcare System, West Haven, Connecticut; Currently with Yale University, New Haven, Connecticut, USA robert.kerns@va.gov.
Office of Disease Prevention and Health Promotion · USAgency for Healthcare Research and Quality · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdverse drug events (ADEs) have been highlighted as a major patient safety and public health challenge by the National Action Plan for Adverse Drug Event Prevention (ADE Action Plan), which was released by the Office of Disease Prevention and Health Promotion (ODPHP) in August 2014. The ADE Action Plan focuses on surveillance, evidence-based prevention, incentives, and oversights, additional research needs as well as possible measures and metrics to track progress of ADE prevention within three drug classes: anticoagulants, diabetes agents, and opioids.Objectives and Recommendations. With outpatient opioid prescriptions being a great concern among many healthcare providers, this article focuses on recommendations from the ADE Action Plan to help guide safer opioid use in healthcare delivery settings. Its aim is to discuss current federal methods in place to prevent opioid ADEs while also providing evidence to encourage providers and hospitals to innovate new systems and practices to increase prevention.

Indexed as

Health Planning GuidelinesAnalgesics, OpioidDrug-Related Side Effects and Adverse ReactionsHealth PolicyHumansOpioid-Related DisordersAnalgesics, OpioidAdverse Drug EventsOpioidsPain ManagementQuality of Healthcare

Identifiers

PMID28025363
PMCPMC6280931
OpenAlexW2403191310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.